compounded under Section 503A for individual prescriptions Hepatic impairment data / no controlled pharmacokinetic studies in liver disease populations Copper clearance / 85-95% of circulating copper is bound to ceruloplasmin, which is synthesized exclusively in the liver [1] Wilson disease parallel / hepatic copper accumulation can reach 250+ mcg/g dry weight in impaired biliary excretion [2] Child-Pugh A / may proceed with standard dosing and baseline copper labs Child-Pugh B / dose reduction recommended with monthly copper monitoring Child-Pugh C / use generally not recommended due to impaired biliary copper excretion Standard compounded dose / 1-2 mg subcutaneously daily or 3 times weekly Key monitoring labs / serum copper, ceruloplasmin, 24-hour urine copper, liver function tests What Is GHK-Cu and How Does It Work
Similarly, evidence for antibodies against HSV-1 (127), EBV (127, 130, 131), and HHV-6 (130) dUTPase proteins has been identified in ME/CFS
Purification and characterization of two extracellular alkaline phosphatases from a psychrophilic arthrobacter isolate
J Pharm Biomed Anal 252:116498
Beware of unauthentic/alternate formulations of these medications, as they tend not to be FDA-regulated and can pose health risks
